Walleye Capital LLC Edwards Lifesciences Corp Call Options Transaction History

Walleye Capital LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $1.05 Million - $1.65 Million	-17,600 Reduced 44.9%	21,600 $1.43 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $1.82 Million - $2.04 Million	21,600 Added 122.73%	39,200 $3.62 Million
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $4.13 Million - $5.44 Million	-56,900 Reduced 76.38%	17,600 $1.68 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $2.34 Million - $2.95 Million	37,900 Added 103.55%	74,500 $5.68 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $561,168 - $756,378	-8,100 Reduced 18.12%	36,600 $2.54 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $1.51 Million - $1.75 Million	18,600 Added 71.26%	44,700 $4.22 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $1.94 Million - $2.21 Million	26,100 New	26,100 $2.16 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $874,010 - $1.07 Million	-14,200 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $657,732 - $760,038	11,800 Added 491.67%	14,200 $2.62 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $114,936 - $153,720	2,400 New	2,400 $459,000

1,350

456M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.